361 related articles for article (PubMed ID: 18429825)
21. Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity.
Vral A; Willems P; Claes K; Poppe B; Perletti G; Thierens H
Mol Med Rep; 2011; 4(5):901-12. PubMed ID: 21725594
[TBL] [Abstract][Full Text] [Related]
22. BRCA2 is required for ionizing radiation-induced assembly of Rad51 complex in vivo.
Yuan SS; Lee SY; Chen G; Song M; Tomlinson GE; Lee EY
Cancer Res; 1999 Aug; 59(15):3547-51. PubMed ID: 10446958
[TBL] [Abstract][Full Text] [Related]
23. Effect of germ-line genetic variation on breast cancer survival in a population-based study.
Goode EL; Dunning AM; Kuschel B; Healey CS; Day NE; Ponder BA; Easton DF; Pharoah PP
Cancer Res; 2002 Jun; 62(11):3052-7. PubMed ID: 12036913
[TBL] [Abstract][Full Text] [Related]
24. Genetic instability in the RAD51 and BRCA1 regions in breast cancer.
Nowacka-Zawisza M; Bryś M; Romanowicz-Makowska H; Kulig A; Krajewska WM
Cell Mol Biol Lett; 2007; 12(2):192-205. PubMed ID: 17180310
[TBL] [Abstract][Full Text] [Related]
25. [Association of polymorphisms of N372H in BRCA2 gene and 135G/C in RAD51 gene and breast cancers].
Hu R; Wei Y; Jiang WJ; Yao WX; Long QM; Zhang JH; Liang Y; Tang XL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Nov; 39(6):973-5. PubMed ID: 19253839
[TBL] [Abstract][Full Text] [Related]
26. Association of breast cancer risk with a GT dinucleotide repeat polymorphism upstream of the estrogen receptor-alpha gene.
Cai Q; Gao YT; Wen W; Shu XO; Jin F; Smith JR; Zheng W
Cancer Res; 2003 Sep; 63(18):5727-30. PubMed ID: 14522892
[TBL] [Abstract][Full Text] [Related]
27. BRCA2 regulates homologous recombination in response to DNA damage: implications for genome stability and carcinogenesis.
Abaji C; Cousineau I; Belmaaza A
Cancer Res; 2005 May; 65(10):4117-25. PubMed ID: 15899802
[TBL] [Abstract][Full Text] [Related]
28. Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.
Oldenburg RA; Kroeze-Jansema K; Meijers-Heijboer H; van Asperen CJ; Hoogerbrugge N; van Leeuwen I; Vasen HF; Cleton-Jansen AM; Kraan J; Houwing-Duistermaat JJ; Morreau H; Cornelisse CJ; Devilee P
Clin Cancer Res; 2006 Mar; 12(6):1693-700. PubMed ID: 16551851
[TBL] [Abstract][Full Text] [Related]
29. [Is hereditary predisposition to breast cancer linked to BRCA1 a disease of response to genotoxic lesions?].
Feunteun J
C R Seances Soc Biol Fil; 1998; 192(2):235-40. PubMed ID: 9759367
[TBL] [Abstract][Full Text] [Related]
30. Highlight: BRCA1 and BRCA2 proteins in breast cancer.
Daniel DC
Microsc Res Tech; 2002 Oct; 59(1):68-83. PubMed ID: 12242698
[TBL] [Abstract][Full Text] [Related]
31. [The G/C polymorphism of RAD51 gene in breast cancer].
Romanowicz-Makowska H; Smolarz B; Kulig A
Pol Merkur Lekarski; 2006 Jul; 21(121):55-8. PubMed ID: 17007294
[TBL] [Abstract][Full Text] [Related]
32. Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population.
Parvin S; Islam MS; Al-Mamun MM; Islam MS; Ahmed MU; Kabir ER; Hasnat A
Breast Cancer; 2017 Mar; 24(2):229-237. PubMed ID: 27068824
[TBL] [Abstract][Full Text] [Related]
33. Cancer. BRCA2 enters the fray.
Wilson JH; Elledge SJ
Science; 2002 Sep; 297(5588):1822-3. PubMed ID: 12228708
[No Abstract] [Full Text] [Related]
34. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway.
Chen JJ; Silver D; Cantor S; Livingston DM; Scully R
Cancer Res; 1999 Apr; 59(7 Suppl):1752s-1756s. PubMed ID: 10197592
[TBL] [Abstract][Full Text] [Related]
35. DNA damage and repair in gastric cancer--a correlation with the hOGG1 and RAD51 genes polymorphisms.
Poplawski T; Arabski M; Kozirowska D; Blasinska-Morawiec M; Morawiec Z; Morawiec-Bajda A; Klupińska G; Jeziorski A; Chojnacki J; Blasiak J
Mutat Res; 2006 Oct; 601(1-2):83-91. PubMed ID: 16843501
[TBL] [Abstract][Full Text] [Related]
36. Association between DNA damage, DNA repair genes variability and clinical characteristics in breast cancer patients.
Synowiec E; Stefanska J; Morawiec Z; Blasiak J; Wozniak K
Mutat Res; 2008 Dec; 648(1-2):65-72. PubMed ID: 18977234
[TBL] [Abstract][Full Text] [Related]
37. BCoR-L1 variation and breast cancer.
Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
[TBL] [Abstract][Full Text] [Related]
38. High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1/BRCA2 breast cancer.
Kristiansen M; Knudsen GP; Maguire P; Margolin S; Pedersen J; Lindblom A; Ørstavik KH
J Med Genet; 2005 Nov; 42(11):877-80. PubMed ID: 15879497
[TBL] [Abstract][Full Text] [Related]
39. DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population.
Costa S; Pinto D; Pereira D; Rodrigues H; Cameselle-Teijeiro J; Medeiros R; Schmitt F
Breast Cancer Res Treat; 2007 Jun; 103(2):209-17. PubMed ID: 17063276
[TBL] [Abstract][Full Text] [Related]
40. The molecular pathology of hereditary breast cancer.
Palacios J; Robles-Frías MJ; Castilla MA; López-García MA; Benítez J
Pathobiology; 2008; 75(2):85-94. PubMed ID: 18544963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]